perifosine   Click here for help

GtoPdb Ligand ID: 7424

Synonyms: D 21266 | KRX-0401 | NSC 639966
Compound class: Synthetic organic
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 0
Rotatable bonds 20
Topological polar surface area 68.4
Molecular weight 461.36
XLogP 8.31
No. Lipinski's rules broken 2
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCCCCCCCCCCCCCCCCCOP(=O)(OC1CC[N+](CC1)(C)C)[O-]
Isomeric SMILES CCCCCCCCCCCCCCCCCCOP(=O)(OC1CC[N+](CC1)(C)C)[O-]
InChI InChI=1S/C25H52NO4P/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-24-29-31(27,28)30-25-20-22-26(2,3)23-21-25/h25H,4-24H2,1-3H3
InChI Key SZFPYBIJACMNJV-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
Perifosine is a potential cancer therapeutic. Orphan drug status for multiple myeloma was withdrawn by the European Medicines Agency in early 2014, at the manufacturer's request. Visit ClinicalTrials.gov to view currently registered drug trials involving this compound.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
Perifosine acts as an Akt inhibitor and a PI3K inhibitor. Inhibition of Akt (PKB) kinase reduces cellular proliferation.